- Home
- OCGN vs AMBI Comparison
OCGN vs AMBI Comparison
Compare OCGN & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- AMBI
- Stock Information
- Founded
- OCGN 2013
- AMBI 1995
- Country
- OCGN United States
- AMBI Brazil
- Employees
- OCGN N/A
- AMBI N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- AMBI Environmental Services
- Sector
- OCGN Health Care
- AMBI Industrials
- Exchange
- OCGN Nasdaq
- AMBI Nasdaq
- Market Cap
- OCGN 283.3M
- AMBI 265.0M
- IPO Year
- OCGN N/A
- AMBI N/A
- Fundamental
- Price
- OCGN $1.05
- AMBI $5.07
- Analyst Decision
- OCGN Strong Buy
- AMBI
- Analyst Count
- OCGN 3
- AMBI 0
- Target Price
- OCGN $6.00
- AMBI N/A
- AVG Volume (30 Days)
- OCGN 2.6M
- AMBI 6.0K
- Earning Date
- OCGN 08-01-2025
- AMBI 01-01-0001
- Dividend Yield
- OCGN N/A
- AMBI N/A
- EPS Growth
- OCGN N/A
- AMBI N/A
- EPS
- OCGN N/A
- AMBI N/A
- Revenue
- OCGN $4,754,000.00
- AMBI $525,221,427.00
- Revenue This Year
- OCGN N/A
- AMBI N/A
- Revenue Next Year
- OCGN N/A
- AMBI N/A
- P/E Ratio
- OCGN N/A
- AMBI N/A
- Revenue Growth
- OCGN N/A
- AMBI 25.42
- 52 Week Low
- OCGN $0.52
- AMBI $3.70
- 52 Week High
- OCGN $1.40
- AMBI $8.20
- Technical
- Relative Strength Index (RSI)
- OCGN 53.85
- AMBI 55.37
- Support Level
- OCGN $1.01
- AMBI $4.77
- Resistance Level
- OCGN $1.07
- AMBI $5.25
- Average True Range (ATR)
- OCGN 0.05
- AMBI 0.23
- MACD
- OCGN 0.00
- AMBI 0.03
- Stochastic Oscillator
- OCGN 66.48
- AMBI 62.03
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.